HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Khurum Khan Selected Research
Khurum Khan Research Topics
Disease
14
Neoplasms (Cancer)
03/2022 - 10/2013
13
Colorectal Neoplasms (Colorectal Cancer)
02/2024 - 09/2014
5
Neoplasm Metastasis (Metastasis)
12/2021 - 09/2014
2
Adenocarcinoma
05/2024 - 12/2014
2
Cholangiocarcinoma
02/2024 - 01/2018
2
Gastrointestinal Neoplasms (Gastrointestinal Cancer)
03/2022 - 08/2020
2
COVID-19
01/2022 - 01/2020
2
Pancreatic Neoplasms (Pancreatic Cancer)
01/2019 - 03/2016
1
Disease Progression
02/2024
1
Breast Neoplasms (Breast Cancer)
03/2022
1
Carcinogenesis
06/2020
1
Vasovagal Syncope
01/2020
1
Hematuria
01/2020
1
Thrombosis (Thrombus)
01/2020
1
Pain (Aches)
01/2020
1
Hematoma
01/2020
1
Sepsis (Septicemia)
01/2020
1
Melanoma (Melanoma, Malignant)
01/2019
1
Myocardial Infarction
01/2019
1
Fatigue
02/2015
1
Exanthema (Rash)
02/2015
1
Stomatitis
02/2015
1
Diarrhea
02/2015
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2013
1
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
10/2013
Drug/Important Bio-Agent (IBA)
6
Biomarkers (Surrogate Marker)
IBA
02/2024 - 03/2016
4
regorafenib
IBA
02/2024 - 01/2018
3
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
07/2019 - 02/2015
2
Interferons
IBA
07/2019 - 01/2019
2
Cetuximab (Erbitux)
FDA Link
01/2019 - 03/2016
2
folfirinox
IBA
01/2019 - 12/2014
1
Phosphotransferases (Kinase)
IBA
02/2024
1
Circulating MicroRNA
IBA
02/2024
1
Poly(ADP-ribose) Polymerase Inhibitors
IBA
03/2022
1
Platinum
IBA
03/2022
1
Albumins
IBA
01/2022
1
C-Reactive Protein
IBA
01/2022
1
boldenone undecylenate (Equipoise)
IBA
04/2021
1
Protein Kinases (Protein Kinase)
IBA
06/2020
1
Tyrosine Kinase Inhibitors
IBA
06/2020
1
trametinib
IBA
01/2019
1
cibisatamab
IBA
01/2019
1
raltitrexed (D 1694)
IBA
01/2019
1
Calcibiotic Root Canal Sealer
IBA
01/2019
1
Antigens
IBA
01/2019
1
Antineoplastic Agents (Antineoplastics)
IBA
01/2018
1
Complement System Proteins (Complement)
IBA
01/2018
1
Heat-Shock Proteins (Heat-Shock Protein)
IBA
01/2018
1
Carcinoembryonic Antigen
IBA
12/2016
1
Fluorine
IBA
12/2016
1
Panitumumab (Vectibix)
FDA Link
05/2016
1
Cyclophosphamide (Cytoxan)
FDA Link
Generic
03/2015
1
Lipase (Acid Lipase)
FDA Link
02/2015
1
MK 2206
IBA
02/2015
1
AZD 6244
IBA
02/2015
1
Carboplatin (JM8)
FDA Link
Generic
10/2013
1
Gemcitabine
FDA Link
10/2013
Therapy/Procedure
11
Therapeutics
05/2024 - 10/2013
6
Drug Therapy (Chemotherapy)
05/2024 - 10/2013
3
Immunotherapy
08/2020 - 01/2019
2
Radiotherapy
11/2020 - 03/2016
1
Aftercare (After-Treatment)
12/2021
1
Combined Modality Therapy
11/2020
1
Conservative Treatment
01/2020
1
Neoadjuvant Therapy
09/2014